IP Library Granted Patent US 11,446,524
Granted Patent B2
US 11,446,524 · App. 15/021,555 · Granted Sep 20, 2022

Systems, devices, and methods for treating a pulmonary disease with ultrasound energy

Inventors: Martin L. Mayse (Wayzata, MN); Steven P. Mertens (Plymouth, MN); Steven C. Dimmer (Bellvue, WA)
Assignee: Nuvaira Inc.
A61N7/02A61B18/04A61B18/1492A61N7/022A61B2018/00011A61B2018/00023A61B2018/00279A61B2018/00285A61B2018/00541A61B2018/00577A61M25/10A61N2007/003A61N2007/0078
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,446,524
App. No.
15/021,555
Granted
Sep 20, 2022
Kind
B2
Abstract

A pulmonary treatment system includes a compact configuration for delivery to an airway of a patient. An energy delivery system of the pulmonary treatment system delivers ultrasound energy to target nerve tissue in or along an airway wall of the airway radially outward from surface tissue to reduce airway resistance in a downstream airway. The pulmonary treatment system may protect tissue in the airway wall of the airway located between the target nerve tissue and the ultrasound energy delivery system by a coolant system that may also act as a coupling fluid for the emitted ultrasound energy.

Claims (14)

1. A pulmonary treatment system, comprising:

an elongate body; and

an ultrasound energy delivery assembly coupled to a distal end of the elongate body and being positionable into an airway of a patient, the airway having first and second interior surfaces on opposing sides thereof, wherein the ultrasound energy delivery assembly comprises an apposition member, a fluid conduit having an elongate portion extending along an exterior surface of the apposition member, and an ultrasound energy delivery element extending along the elongate portion of the fluid conduit, the ultrasound energy delivery assembly being movable from a delivery state to a deployed state,

wherein the apposition member is configured to urge the fluid conduit closer to and into contact with the first interior surface of the airway when the ultrasound energy delivery assembly is in the deployed state to position the ultrasound delivery element closer to a treatment site located radially outward from the first interior surface,

wherein, in the deployed state, the elongate portion of the fluid conduit with the ultrasound energy delivery element extends longitudinally along the exterior surface of the apposition member and parallel to a longitudinal axis of the apposition member, the ultrasound delivery element being positioned outside of the fluid conduit between the fluid conduit and the apposition member such that the ultrasound delivery element is completely or substantially concealed between the fluid conduit and the apposition member, and

wherein the ultrasound energy delivery element is configured to deliver ultrasound energy to the treatment site.

2. The pulmonary treatment system of claim 1 , wherein the apposition member is configured to urge the ultrasound delivery element away from the second interior surface of the airway wall when moved from the delivery state to the deployed state.

3. The pulmonary treatment system of claim 2 , wherein the apposition member comprises an expandable member for moving the ultrasound energy delivery assembly from the delivery state to the deployed state.

4. The pulmonary treatment system of claim 3 , wherein the expandable member is in fluid communication with a supply lumen and a return lumen to enable an acoustic coupling fluid to circulate through the expandable member.

5. The pulmonary treatment system of claim 3 , wherein the expandable member comprises an inflatable balloon.

6. The pulmonary treatment system of claim 3 , wherein the expandable member comprises an expandable basket structure.

7. The pulmonary treatment system of claim 1 , wherein the ultrasound energy delivery element is positioned on an exterior surface of the fluid conduit.

8. The pulmonary treatment system of claim 1 , wherein the ultrasound delivery element extends parallel to a longitudinal axis of the fluid conduit.

9. The pulmonary treatment system of claim 1 , wherein the fluid conduit is configured for fluid circulation therethrough to remove heat from tissue abutting the tissue contacting surface of the fluid conduit during ultrasound energy delivery to the treatment site by the ultrasound delivery element.

Assignments (4)
SECURITY INTEREST Recorded Oct 16, 2024
From: NUVAIRA, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND 1, LP
Reel/Frame 069175/0918 →
SECURITY INTEREST Recorded Dec 21, 2021
From: NUVAIRA, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND 1, LP
Reel/Frame 058561/0979 →
CHANGE OF NAME Recorded Jun 20, 2017
From: HOLAIRA, INC.
To: NUVAIRA, INC.
Reel/Frame 042915/0068 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2016
From: MAYSE, MARTIN L.; MERTENS, STEVEN P.; DIMMER, STEVEN C.
To: HOLAIRA, INC.
Reel/Frame 039431/0913 →
Continuity (2)
Provisional Application 61876925 · Sep 12, 2013
Related Publication 20160220851A1 · Aug 4, 2016
Cited By (3)
US 12,502,559 US 12,582,847 US 12,594,438